Make an enquiry

Refer a patient

Patient Portal

Healthcare Professionals
Research and insights
Publications
Treatment outcome, toxicity, and predictive factors for radioligand therapy with 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer

22 Nov 2018

Treatment outcome, toxicity, and predictive factors for radioligand therapy with 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer

Written by

Heck M; Tauber R; Schwaiger S et al.;